Wednesday, September 27, 2023 |

Rockville biotech OpGen faces delisting threat from Nasdaq

June 14, 2023

Rockville’s OpGen Inc. (NASDAQ: OPGN) has fallen out of compliance with the Nasdaq Stock Market after its share price failed to crack a buck over a 30-day period. The 20-year-old biotech said in filings with the Securities and Exchange Commission that it received a letter from the exchange June 5 about the need to maintain the minimum bid price of $1, per its listing rules. OpGen has 180 days to regain compliance.

Article Source: Baltimore Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.